ShangPharma

Celgene, Skyhawk launch $60M collaboration in ALS, Huntington’s

Celgene launched a $60 million collaboration with Skyhawk Therapeutics to develop small molecules targeting RNA mis-splicing in neurological diseases.

Conor Hale Jun 26, 2018 7:49am

ShangPharma boosts Bay Area reach for early-stage research

Mar 19, 2018 9:50am

Editas backer Partners taps Lilly to help raise $171M fund

Nov 9, 2017 6:48am